Istradefylline
CAS 155270-99-8 5 FDA-DMF suppliersSmall Molecule
Overview
Istradefylline is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL431770).
Patent & exclusivity (US)
Per the FDA Orange Book (2 approved US products), the latest listed US patent on Istradefylline expires 28 Jan 2028. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- 8-[(E)-2-(3,4-dimethoxyphenyl)ethenyl]-1,3-diethyl-7-methylpurine-2,6-dione
- Canonical SMILES
- CCN1C2=C(C(=O)N(C1=O)CC)N(C(=N2)/C=C/C3=CC(=C(C=C3)OC)OC)C
- InChIKey
- IQVRBWUUXZMOPW-PKNBQFBNSA-N
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.